How EMG/NCS Results Can Change a Patient’s Treatment Plan

The Clinical & Business Connection Newsletter

Clinical Insight

Referring for EMG/NCS is often framed, understandably, as a confirmatory step — a way to validate a working diagnosis before proceeding with a planned treatment. In practice, the electrodiagnostic result frequently does more than confirm: it redirects the plan, sometimes substantially, in ways that pure clinical exam and imaging cannot.

Overlapping presentations are the norm, not the exception, in patients with radicular, peripheral, or diffuse extremity symptoms. Radiculopathy, peripheral entrapment neuropathy, plexopathy, and generalized polyneuropathy (diabetic, idiopathic, or otherwise) can all produce similar patient-reported symptoms — pain, numbness, weakness — while requiring meaningfully different management. EMG/NCS is the tool that localizes and characterizes the lesion rather than inferring it from symptom pattern alone.

Where Results Commonly Redirect Management

• Localization: distinguishing a cervical or lumbar radiculopathy from a peripheral entrapment (e.g., carpal or cubital tunnel) changes the referral pathway entirely — spine versus peripheral nerve management

• Severity grading: mild, demyelinating-predominant findings often support a conservative trial (splinting, PT, activity modification), while significant axonal loss can justify earlier surgical or specialist referral rather than a prolonged conservative period

• Ruling out neuropathy: in patients with diffuse symptoms and a suspected but unconfirmed radiculopathy, a normal EMG proximal to the suspected level can redirect workup toward a metabolic, rheumatologic, or central cause

• Pre-procedural planning: for patients being considered for injection or surgical intervention, confirmed localization improves the precision and expected yield of the planned intervention

The Practical Value of a Negative Study

A negative or normal EMG is not a wasted test — it’s a redirection. It tells you the presenting symptoms are not explained by the nerve or muscle pathology you were screening for, which is often exactly the information needed to stop an ineffective treatment trajectory before it consumes further visits and time. The clinical value of electrodiagnostic testing lies as much in what it rules out as in what it confirms.

This isn’t just a theoretical claim. In a multicenter outpatient study co-authored by Dr. Dimitrios Kostopoulos (462 patients), EMG/NCS testing led to a change in clinical management in up to 61% of patients — with a change in diagnosis in 39% of cases.

That’s the practical weight electrodiagnostic findings carry: in more than half of cases studied, the test didn’t just confirm the plan already in motion — it changed it.

References

1. Rawat, M., Kostopoulos, D., Rizopoulos, K., Dodson, W., Blair, K., Henderson, J., Grow, M., & Upreti, C. (2020). Impact of electrodiagnostic (EMG/NCS) tests on clinical decision-making and patient perceived benefit in the outpatient physical therapy practice. Journal of Bodywork and Movement Therapies, 24(1), 170–174.

Business Success Strategy

The Hidden Cost of Delayed Diagnostic Testing

When electrodiagnostic testing is delayed or deferred in favor of a conservative trial-and-see approach, the cost rarely shows up as a single line item — it accumulates quietly across the patient’s course of care, and it’s worth naming plainly as a practice-management consideration, not just a clinical one.

Where the Cost Actually Lands

• Additional office visits: unresolved symptoms bring patients back for repeat evaluation, often multiple times, before a definitive diagnostic step is finally taken

• Prolonged, ineffective treatment: without localization, treatment plans are built on a working hypothesis rather than a confirmed diagnosis — time and resources go toward managing the wrong problem

• Patient frustration and attrition: patients who feel like they’re not getting answers are more likely to seek a second opinion elsewhere, taking the case (and the relationship) with them

• Slower clinical decision-making: every cycle of “try this, see if it helps” without objective data adds weeks to the timeline before a definitive treatment path is set

Early electrodiagnostic referral doesn’t add a step to the process — it removes the guesswork from several steps that would otherwise happen anyway. For practices managing high patient volumes, that’s not just better care; it’s fewer unresolved return visits and a faster path to patient satisfaction and retention.

If early testing isn’t yet a standard part of your workup for ambiguous extremity or radicular symptoms, it’s worth revisiting where in your current pathway a faster EMG referral would save the most downstream time — both yours and your patient’s.

If your patient’s symptoms don’t fit neatly into a single diagnosis — or a treatment plan isn’t working the way you expected — an EMG/NCS referral can close that gap quickly. Refer today at HappierPatients.com and give your patient a faster path to an accurate answer

Spotlight on Excellence

Elan Etstein

Chief Marketing Officer

Elan Etstein serves as the Chief Marketing Officer of Hands-On EMG Testing, bringing over 15 years of specialized experience in referral management and business development within the healthcare industry.

Throughout his career, Elan has cultivated and maintained trusted relationships with hundreds of physicians, attorneys, and healthcare professionals across the New York City and Long Island regions. His extensive network of referring providers, combined with his deep understanding of patient care pathways, has played a key role in expanding access to advanced diagnostic testing services for countless patients.

Driven by a passion to inspire others to improve their health and reach their full potential, Elan takes great pride in contributing to each patient’s recovery journey — ensuring that referring providers and patients alike benefit from timely, accurate, and clinically meaningful diagnostic evaluations.

Under his leadership, Hands-On EMG Testing continues to grow as a trusted partner to the medical and legal communities, delivering high-quality, evidence-based diagnostic services that support optimal patient outcomes.

Updates You Should Know

The Introduction to EMG, Nerve Conduction Studies, and Musculoskeletal Ultrasound Imaging course just wrapped — and it was a phenomenal success.

Hands-On EMG Testing hosted the American Academy of Clinical Electrodiagnosis (AACE) and the American Academy of MSK Ultrasound (AAMU) for the Introduction to EMG, Nerve Conduction Studies, and Musculoskeletal Ultrasound Imaging with 40+ clinicians gathering for two days of intensive, hands-on training.

Attendees left with:

• Real-world skills in EMG, nerve conduction studies, and MSK ultrasound imaging
• The clinical context needed to make more confident, accurate referrals
• 20.5 CEUs (physical therapy professionals) or 20.5 CMEs (physicians and medical providers)
• A direct connection to the HODS Leadership Team, who works personally with your admin and marketing staff to tailor strategies for your practice and market

The energy in the room was electric — and the demand is only growing!

Want in on the next one? For all upcoming dates and locations please visit emgintro.com.

How We Can Help

Hands-On EMG Testing serves physicians and patients across several locations in Manhattan, Queens, the Bronx, Brooklyn, and Long Island.

To refer a patient, please use our online referral form. To learn more about our services, email in**@********mg.com, or call +1 (855) 248-4021.

If you are interested in incorporating our Medical Diagnostic Model into your practice to provide immediate testing results and create a strong business opportunity, please contact Dr. Dimitrios Kostopoulos at di**@********mg.com.